C. Moreno

Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.

M. Ritter, A. Epenetos, J. Corvalan, 1991, British Journal of Cancer.

The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation.

E. Bandrés, J. Merino, M. Subirá, 2000, Clinical immunology.

Anti‐Inflammatory Cytokines Induce Lipopolysaccharide Tolerance in Human Monocytes Without Modifying Toll‐Like Receptor 4 Membrane Expression

J. Merino, F. Pastor, A. Sánchez-Ibarrola, 2004, Scandinavian journal of immunology.

Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

J. Cigudosa, J. Martinez-Climent, F. Prósper, 2011, Leukemia.

BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus‐specific human CD8+ T cells

J. Merino, A. Sánchez-Ibarrola, N. Ramírez, 2007, Clinical and experimental immunology.